Uplizna 100 mg/10 mL injection Images
Generic Name: inebilizumab
This medication has been identified as Uplizna 100 mg/10 mL injection and is used for Immunoglobulin G4-Related Disease, and Neuromyelitis Optica Spectrum Disorder. It belongs to the drug class selective immunosuppressants and is not a controlled substance.
Images of medication
Uplizna
- Generic Name
- inebilizumab
- Strength
- 100 mg/10 mL injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Viela Bio, Inc.
- National Drug Code (NDC)
- 72677-0551 (Discontinued)
See also:
More about Uplizna (inebilizumab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.